
UNH
UnitedHealth Group Incorporated · NYSE
$512.60+0.97%
9 Sep close- Market cap
- $472B
- Sector
- Health care
Income statement
Revenue, costs and earnings
Loading

| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | 31 Dec 16 | 31 Dec 17 | 31 Dec 18 | 31 Dec 19 | 31 Dec 20 | 31 Dec 21 | 31 Dec 22 | 31 Dec 23 | 31 Dec 24 | 31 Dec 25 | 30 Jun 26 | Each line by period |
| Revenue | $159.3B | $186.4B | $212.5B | $229.0B | $257.1B | $287.6B | $324.2B | $371.6B | $400.3B | $428.5B | $442.8B | |
| Cost of revenue | −$120.3B | −$140.8B | −$160.4B | −$172.9B | −$194.1B | −$218.2B | −$247.3B | −$284.8B | −$308.4B | −$331.7B | −$344.5B | |
| Gross profit | $39.0B | $45.7B | $52.0B | $56.1B | $63.0B | $69.4B | $76.9B | $86.8B | $91.9B | $96.8B | $98.3B | |
| Operating costs | −$15.9B | −$18.6B | −$21.2B | −$22.8B | −$25.6B | −$29.4B | −$33.0B | −$37.8B | −$39.9B | −$42.7B | −$42.1B | |
| Cost of products sold | −$6.7B | −$7.8B | −$8.9B | −$9.6B | −$10.8B | −$12.3B | −$13.8B | −$15.8B | −$16.7B | −$17.9B | −$17.6B | |
| Depreciation and amortisation | −$3.1B | −$3.6B | −$4.1B | −$4.4B | −$5.0B | −$5.7B | −$6.4B | −$7.3B | −$7.7B | −$8.3B | −$8.1B | |
| Restructuring and other charges | −$0.4B | −$0.4B | −$0.5B | −$0.5B | −$0.6B | −$0.4B | −$1.6B | −$2.1B | −$2.9B | −$1.6B | −$3.0B | |
| Operating income | $13.1B | $15.3B | $17.4B | $18.8B | $21.1B | $21.5B | $22.2B | $23.8B | $24.7B | $26.3B | $27.4B | |
| Operating margin | 8.2% | 8.2% | 8.2% | 8.2% | 8.2% | 7.5% | 6.8% | 6.4% | 6.2% | 6.1% | 6.2% | |
| Other income and expense, net | −$0.3B | −$0.4B | −$0.4B | −$0.5B | −$0.5B | −$0.7B | −$0.9B | −$1.1B | −$1.3B | −$1.6B | −$1.8B | |
| Income before taxes | $12.7B | $14.9B | $17.0B | $18.3B | $20.6B | $20.8B | $21.3B | $22.7B | $23.4B | $24.7B | $25.7B | |
| Income tax expense | −$2.9B | −$3.4B | −$3.8B | −$4.1B | −$4.6B | −$4.7B | −$4.8B | −$5.2B | −$5.3B | −$5.7B | −$5.9B | |
| Net income | $9.9B | $11.6B | $13.2B | $14.2B | $15.9B | $16.1B | $16.5B | $17.5B | $18.0B | $19.1B | $19.8B | |
| Diluted shares, billions | 0.98 | 0.97 | 0.97 | 0.96 | 0.95 | 0.95 | 0.94 | 0.94 | 0.93 | 0.93 | 0.92 | |
| Diluted earnings per share | $10.08 | $11.88 | $13.62 | $14.78 | $16.69 | $16.97 | $17.49 | $18.67 | $19.36 | $20.57 | $21.49 | |
| Derived metrics | ||||||||||||
| Revenue growth, period on period | no prior period | +17.0% | +14.0% | +7.8% | +12.3% | +11.9% | +12.7% | +14.6% | +7.7% | +7.0% | +3.3% | |
| Gross margin | 24.5% | 24.5% | 24.5% | 24.5% | 24.5% | 24.1% | 23.7% | 23.4% | 23.0% | 22.6% | 22.2% | |
| Net margin | 6.2% | 6.2% | 6.2% | 6.2% | 6.2% | 5.6% | 5.1% | 4.7% | 4.5% | 4.4% | 4.5% | |
Billions of dollars, except earnings per share in dollars and the share count in billions. Growth is on the period before; the trailing twelve months is on the last full period.